N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in 3 Adults With Williams Syndrome
NAC was effective for treating NSSIB in 3 adults with WS. By addressing these challenging behaviors, NAC offers a promising pharmacological intervention that can significantly improve the quality of life for patients with WS who engage in NSSIB. Further research and clinical trials are necessary.
Authors
- Robyn P. Thom (ORCID: https://orcid.org/0000-0002-8026-6970)
- Christopher J. McDougle (ORCID: https://orcid.org/0000-0002-6229-9293)
- Hagar Kandel
- Alberto Cruz
Institutions
- Harvard University (US)
- Weatherford College (US)
- Massachusetts General Hospital (US)
- Riverkeeper (US)
- Center for Autism and Related Disorders (US)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1097/jcp.0000000000001976
- Citations
- 1
- Primary Topic
- Williams Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 1.32